Purchase Order N3239824P0035
Award Date 7/1/24
Potential Completion Date 6/30/25
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
- This is a firm fixed price delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $110,534.40 contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is issued under...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This is a firm fixed-price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $38,027.60 award is for the provision of lab supplies, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. This Delivery Order is likely part of a larger Indefinite...
- This $13,447.16 firm fixed price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is to provide a NextSeq DNA library preparation kit and related consumables to support nucleic acid sequencing capabilities at the Naval Health Research Center's Biological Defense Research Directorate in San Diego, California. The award is not associated with a larger...
- This is a $194,653.66 firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc. for the provision of sequencing instruments, reagents, and related services. The contract, which does not have a set-aside designation, supports Illumina's provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables, sample prep kits, sequencing chips, maintenance, and bioinformatics...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $68,512.50, is for the delivery of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models, along with accompanying reagents, consumables, and support services. The contract is not designated as a set-aside. Illumina has...
- This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...